Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Sales (2018 - 2025)

Dna X (SONM) has disclosed Return on Sales for 8 consecutive years, with 0.29% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 13.0% year-over-year to 0.29%, compared with a TTM value of 0.51% through Sep 2025, down 27.0%, and an annual FY2024 reading of 0.59%, down 59.0% over the prior year.
  • Return on Sales was 0.29% for Q3 2025 at Dna X, up from 0.67% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.53% in Q4 2022 and bottomed at 0.98% in Q4 2024.
  • Average Return on Sales over 5 years is 0.32%, with a median of 0.29% recorded in 2025.
  • The sharpest move saw Return on Sales surged 127bps in 2022, then tumbled -88bps in 2024.
  • Year by year, Return on Sales stood at 0.74% in 2021, then soared by 172bps to 0.53% in 2022, then tumbled by -119bps to 0.1% in 2023, then tumbled by -876bps to 0.98% in 2024, then surged by 70bps to 0.29% in 2025.
  • Business Quant data shows Return on Sales for SONM at 0.29% in Q3 2025, 0.67% in Q2 2025, and 0.03% in Q1 2025.